The North America Digestive Enzyme Supplements Market would witness market growth of 6.5% CAGR during the forecast period (2022-2028).
Several enzymes from the stem or pulp of pineapples are used to make bromelain. Because it aids in protein digestion, bromelain is regarded to be beneficial in easing stomach symptoms as well as inflammation brought on by injury or infection. Research on bromelain's efficacy in reducing arthritis pain has yielded some contradictory results. There is a lot of anecdotal support for the use of bromelain as a digestive aid, but little formal study support.
Bromelain should normally be taken with meals multiple times a day and the dosage recommendations may vary. It is essential to receive a doctor's approval before taking bromelain because it may interfere with the way prescription medications work. Supplementing with digestive enzymes seems to be a relatively risk-free way to treat digestive problems. It may be less certain, though, whether the consumer would notice a significant improvement in the symptoms.
IBS, or Irritable Bowel Syndrome, is a very common disease in regional countries. According to the Canadian Psychology Association, Canada has a wide prevalence of IBS. Irritable bowel syndrome (IBS) symptoms include lower abdominal pain or discomfort as well as frequent, severe diarrhea or constipation. Bloating is an additional typical symptom. IBS is a gastrointestinal (GI) tract illness that affects the lower gut. It is believed to be an issue with the way the gut functions. It is believed to be the result of issues with gut-brain communication.
The US market dominated the North America Digestive Enzyme Supplements Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $382.6 Million by 2028.The Canada market is poised to grow at a CAGR of 8.9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.9% during (2022 - 2028).
Based on Application, the market is segmented into Additional supplements, Medical & Infant Nutrition and Sports Nutrition. Based on Origin, the market is segmented into Animal, Plant, Microbial and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Digestive Enzyme Supplements Market is Estimated to reach $1.5 Billion by 2028, at a CAGR of 7.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ProThera, Inc., Enzymes, Inc., AST Enzymes, Vemo 99 Ltd., Zeus Biotech Pvt. Ltd., Metagenics, Inc., Xymogen, HVL, LLC, Ortho Molecular Products, Inc., and Enzymedica, Inc.
By Application
By Origin
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
